CIBC Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $983K | Sell |
|
|||||
|
2025
Q1 | $1.07M | Sell |
|
|||||
|
2024
Q4 | $1.35M | Sell |
|
|||||
|
2024
Q3 | $1.48M | Buy |
|
|||||
|
2024
Q2 | $1.43M | Sell |
|
|||||
|
2024
Q1 | $1.96M | Buy |
|
|||||
|
2023
Q4 | $1.66M | Sell |
|
|||||
|
2023
Q3 | $1.42M | Sell |
|
|||||
|
2023
Q2 | $1.53M | Sell |
|
|||||
|
2023
Q1 | $1.49M | Buy |
|
|||||
|
2022
Q4 | $1.55M | Buy |
|
|||||
|
2022
Q3 | $1.32M | Buy |
|
|||||
|
2022
Q2 | $1.3M | Buy |
|
|||||
|
2022
Q1 | $1.36M | Buy |
|
|||||
|
2021
Q4 | $1.78M | Buy |
|
|||||
|
2021
Q3 | $1.83M | Buy |
|
|||||
|
2021
Q2 | $1.58M | Buy |
|
|||||
|
2021
Q1 | $531K | Sell |
|
|||||
|
2020
Q4 | $483K | Hold |
|
|||||
|
2020
Q3 | $438K | Buy |
|
|||||
|
2020
Q2 | $329K | Hold |
|
|||||
|
2020
Q1 | $238K | Hold |
|
|||||
|
2019
Q4 | $288K | Buy |
|
|||||
|
2019
Q3 | $222K | Hold |
|
|||||
|
2019
Q2 | $238K | Hold |
|
|||||
|
2019
Q1 | $244K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $226K | Buy |
|